Safety, Tolerability and Efficacy of NPI-001 in Patients With Hereditary Cystatin C Amyloid Angiopathy (HCCAA)
Clinical trial NCT07716865 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07716865
- Sponsor
- Arctic Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-03
- Primary completion
- 2026-12-29
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.